Veritone, Inc. Files Q3 2025 10-Q/A Restatement: Critical Updates for Investors

Summary of Restatement

Veritone, Inc. has filed an Amendment No. 1 on Form 10-Q/A for the quarter ended September 30, 2025, which includes a restatement of its unaudited condensed consolidated financial statements. The restatement also revises the financial statements for the period ended June 30, 2025. This action follows the original filings made on November 7, 2025, and August 8, 2025, respectively.

Key Points and Issues Identified

• Material Errors Detected:
  • Understatement of goodwill by \$1.0 million (approx. 2% of previously reported).
  • Understatement of intangible assets, net by \$0.5 million (approx. 1% of previously reported).
  • Overstatement of accumulated other comprehensive income (loss) by \$1.5 million (246% of previously reported).
  • Foreign currency translation adjustments were also misstated: overstatement of \$0.4 million for the three months ended September 30, 2025, and understatement of \$1.5 million for the nine months ended September 30, 2025.
• Additional Immaterial Errors:
  • Management identified further immaterial errors in the unaudited condensed consolidated interim financial statements for Q2 2025. These errors have been corrected in the restated report.
• Internal Control Deficiencies:
  • Management previously disclosed that disclosure controls and procedures were not effective at December 31, 2024, March 31, 2025, June 30, 2025, and September 30, 2025 due to material weaknesses in internal control over financial reporting.
  • With the Q3 2025 restatement, an additional material weakness was identified relating to revenue recognition, particularly for non-routine revenue transactions.
• Company Status:
  • Veritone, Inc. is categorized as an “Accelerated filer” and a “Smaller reporting company”.
  • Not an emerging growth company or shell company.
• Shares Outstanding:
  • Common stock outstanding as of October 31, 2025: 91,806,023 shares.
  • Shares issued and outstanding as of September 30, 2025: 40,948,000.
• Financial Highlights (Restated):
  • Total assets as of September 30, 2025: \$198.6 million.
  • Stockholders’ equity as of September 30, 2025: \$15.5 million.
  • Net loss for nine months ended September 30, 2025: \$29.2 million.
  • Revenue for nine months ended September 30, 2025: \$26.6 million.
  • Loss per share from continuing operations (basic and diluted): \$0.45 for Q3 2025, \$0.59 for Q2 2025, and \$1.39 for the nine months ended September 30, 2025.
  • Weighted average diluted shares outstanding for nine months ended September 30, 2025: 54 million.

Potential Price-Sensitive Information

• Restatement and Internal Control Weaknesses:

  The restatement of financial statements and identification of material weaknesses in internal controls, particularly regarding revenue recognition, are significant issues. These could affect investor confidence and potentially impact the company’s share price.

• Ongoing Business Risks:

  Veritone highlighted several risks in its forward-looking statements, including concerns about its ability to continue as a going concern, reliance on key customers, requirements for additional capital, and challenges related to the integration of acquisitions and divestitures.

• Market and Economic Risks:

  The company notes risks from macroeconomic and geopolitical disruptions, including inflation, high interest rates, and conflicts such as Russia-Ukraine and Israel-Hamas, which may affect its business and customers.

• Cost Reduction and Growth Initiatives:

  Veritone is undertaking cost reduction efforts and aims to realize benefits from its recent divestitures (e.g., sale of Veritone One) and acquisitions (e.g., Broadbean). The success or failure of these efforts could impact future financial performance and share valuation.

Restated Reporting and SEC Compliance

The amended report is presented as of the original filing date and does not reflect events occurring after that date, except as required to reflect the Q3 2025 restatement and the Q2 2025 revision. Updated signature pages and currently dated certifications from the CEO and CFO are included for compliance.

Items amended in this filing include:

• Part I, Item 1 – Financial Statements (Unaudited)
• Part I, Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations
• Part I, Item 4 – Controls and Procedures
• Part II, Item 1A – Risk Factors
• Part II, Item 6 – Exhibits and Signatures

Investor Implications

The restatement and ongoing internal control concerns are critical for investors. Such issues may lead to increased scrutiny from regulators, potential legal actions, or shifts in investor sentiment. Furthermore, the company’s financial losses, material weaknesses, and requirements for additional capital highlight risks to its financial stability and future performance.

Disclaimer

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should review the full SEC filings and consult with their financial advisors before making any investment decisions. The information provided herein is based on the company’s amended SEC filing and may not reflect subsequent events or disclosures.

View Veritone, Inc. Historical chart here